Hennessy Capital Acquisition Corp. IV (HCAC) 是一家特殊目的收購公司,專注於與科技、醫療保健及消費領域的高增長企業合併。在經驗豐富的管理團隊支持下,HCAC 利用其雄厚財務資源及廣泛行業人脈,尋求創造價值的交易。公司定位優越,能夠把握變革性市場趨勢,為希望捕捉重大增長潛力的機構投資者提供具吸引力的投資機會。
財務指標
營業收入
2026-06-30
$0
2026-03-31
$0
營業支出
2026-06-30
$485.56K
2026-03-31
$183.12K
淨利潤
2026-06-30
$1.37M
2026-03-31
$1.65M
淨利潤率
2026-06-30
--
2026-03-31
--
每股收益
2026-06-30
$0.05
2026-03-31
$0.06
息稅折舊攤銷前利潤
2026-06-30
-$485.56K
2026-03-31
-$183.12K
有效稅率
2026-06-30
--
2026-03-31
--
項目
2026-06-30
2026-03-31
營業收入
$0
$0
營業支出
$485.56K
$183.12K
淨利潤
$1.37M
$1.65M
淨利潤率
--
--
每股收益
$0.05
$0.06
息稅折舊攤銷前利潤
-$485.56K
-$183.12K
有效稅率
--
--
常見問題
HCAC is the ticker symbol for Hennessy Capital Acquisition Corp. IV, a special purpose acquisition company (SPAC) that was formed to merge with or acquire one or more businesses. HCAC stock represents an ownership interest in the SPAC, which holds funds in trust until a business combination is completed. As a SPAC, HCAC does not have operating operations of its own, and its shares may trade based on market expectations about a potential merger target. For the most current status, refer to the latest HCAC data displayed on the page.
HCAC, as a special purpose acquisition company, does not operate in a specific industry. Its purpose is to identify and merge with a private company, which could be in any sector. Therefore, HCAC is typically classified as a blank check company or financial services entity until a merger target is announced. The industry classification may change after a business combination is completed. Investors should review the latest HCAC filings and page data to learn about any announced target or sector focus.
Recent performance of HCAC stock can vary based on market sentiment, merger news, and general market conditions. Since HCAC is a SPAC, its price often trades near its trust value before a merger announcement, but can fluctuate more once a deal is disclosed. For the latest price changes and performance data, please check the current HCAC stock price and performance information displayed on this page. Historical performance does not guarantee future results.
Valuing HCAC requires considering its nature as a SPAC. Before a merger, HCAC's value is largely tied to the cash held in trust per share, which provides a baseline. After a merger is announced, valuation becomes more complex and may involve comparing the target company's financials to peers. Useful metrics include the trust value per share, any merger terms, and the target's projected financials. Because HCAC may not have traditional earnings, standard metrics like P/E may not apply. Check the latest HCAC data and filings for specific figures.
To buy HCAC stock, you need a brokerage account that offers U.S. stock trading. Once your account is funded, you can place a buy order for HCAC shares during market hours. HCAC is typically listed on a major U.S. exchange, such as the Nasdaq or NYSE, so it can be purchased through most online brokers. The process involves searching for the ticker HCAC, selecting the number of shares, and choosing an order type. Always verify the latest HCAC listing details on the page before trading.
Investing in HCAC carries risks specific to SPACs. If no merger is completed within the required timeframe, HCAC may liquidate, and shareholders could receive only the trust value per share, potentially losing any premium paid. After a merger, the stock may be volatile and could decline if the combined company underperforms. Other risks include dilution from warrants, low liquidity, and market-wide factors. Review HCAC's latest SEC filings and page data for detailed risk disclosures.